منابع مشابه
The Heidelberg Bleeding Classification Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy
Intracranial hemorrhage is an important safety end point in clinical trials. Yet, not each intracranial hemorrhage detected by computed tomography (CT) or magnetic resonance imaging (MRI) worsens neurological symptoms and impairs outcomes. Consequently, intracranial hemorrhages after ischemic stroke and reperfusion therapy are classified by both imaging characteristics and the association with ...
متن کاملThe Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy.
Intracranial hemorrhage is an important safety end point in clinical trials. Yet, not each intracranial hemorrhage detected by computed tomography (CT) or magnetic resonance imaging (MRI) worsens neurological symptoms and impairs outcomes. Consequently, intracranial hemorrhages after ischemic stroke and reperfusion therapy are classified by both imaging characteristics and the association with ...
متن کاملRelative familial clustering of cerebral versus coronary ischemic events.
BACKGROUND Few population-based studies have ascertained both cerebral and coronary events or considered their relative heritability. Differences in heritability of transient ischemic attack and ischemic stroke versus acute coronary syndromes (ACS) may inform risk prediction, genetic studies, and understanding of disease mechanisms. METHODS AND RESULTS In a population-based study of all acute...
متن کاملANTI CARDIOLIPIN ANTIBODIES IN PATIENTS WITH ISCHEMIC EVENTS
To determine the presence of anticardiolipin (aCL) antibodies in patients with ischemic events, we designed a case-control study. We studied 33 patients with unstable angina, 33 male patients with myocardial infarction and 34 control subjects with no evidence of ischemic heart disease. Plasma samples were assessed for IgG anticardiolipin antibodies by enzyme-linked immunosorbent assay (ELI...
متن کاملAdding aspirin to clopidogrel increased bleeding without reducing recurrent ischemic vascular events in high-risk patients.
M e t h o d s Design: Randomized, placebo-controlled trial (Management of ATherothrombosis with Clopidogrel in High-risk patients [MATCH]). Allocation: Concealed.* Blinding: Blinded (clinicians, patients, {data collectors, data analysts, and outcome assessors}†).* Follow-up period: 18 months of treatment. Setting: 507 centers (stroke units and neurology departments) in 28 countries. Patients: 7...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JACC: Cardiovascular Interventions
سال: 2016
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2016.09.023